A vs B [Design Issues]

posted by mittyri – Russia, 2020-02-03 21:05 (297 d 03:15 ago) – Posting: # 21136
Views: 1,738

Hi John,

citing our Hero:

If one is really interested in λz and has no SD-phase in the study, sampling should continue until concentrations from previous doses are washed out – I would expect any estimate within the MD-profile to be biased towards faster elimination.

» I have seen both designs but I (and my former bosses) prefer method A. The only drawback I see from A is it takes longer time.

why does A take longer time?

Edit: Changed to internal link; see also this post #7[Helmut]

Kind regards,

Complete thread:

 Admin contact
21,213 posts in 4,426 threads, 1,483 registered users;
online 10 (0 registered, 10 guests [including 8 identified bots]).
Forum time: Friday 00:21 CET (Europe/Vienna)

Biostatistician. One who has neither the intellect for mathematics
nor the commitment for medicine but likes to dabble in both.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz